Insider · CIK 0001831767
Harry Simeonidis
Files at INBS (INTELLIGENT BIO SOLUTIONS INC.). First filing -, latest -.
In brief
Harry Simeonidis files SEC Form 4 as CEO at INBS (INTELLIGENT BIO SOLUTIONS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Harry Simeonidis has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | INBS INTELLIGENT BIO SOLUTIONS INC. | AGrant or award Common Stock | +9,150 | $0.00 | $0 | 13,190 | Mar 20, 2026 |
| Mar 18, 2026 | INBS INTELLIGENT BIO SOLUTIONS INC. | AGrant or award Common Stock | +21,350 | $0.00 | $0 | 34,540 | Mar 20, 2026 |
Questions about Harry Simeonidis
Answered from the filings on this page, as of the latest one.
Is Harry Simeonidis buying or selling?
Harry Simeonidis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Harry Simeonidis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Harry Simeonidis has 0.
Where does Harry Simeonidis file Form 4?
Harry Simeonidis has filed Form 4 at INBS (INTELLIGENT BIO SOLUTIONS INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.